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Abstract 
There is an increasing number of research projects conducted that require the recruitment of 
participants in the pre-hospital or emergency setting. A complicating factor in pre-hospital and 
emergency research (PHER) is that potential participants may lack or lose the capacity to give a valid 
consent. The lack or loss of capacity is ethically and legally complex for researchers and Research 
Ethics Committees (REC) whose approval must be gained prior to commencing a study. This paper 
explores those challenges by drawing upon a number of case studies of pre-hospital research in 
which adult participants are likely to lack the capacity to consent. The paper begins by outlining the 
development of the legal provisions for conducting research with participants unable to consent for 
themselves within the jurisdictions of England and Wales. The paper goes on to explore how 
researchers can meet the legal requirement for research, how to frame the issues for the purposes 
of ethical review, as well as offering ethical guidance for practices within the research field.  
Key words: Mental capacity, research, loss of capacity, MCA (2005), clinical trials, ethics committees, 
pre-hospital research.  
Introduction 
The free and informed consent of a potential research participant is regarded as the fundamental 
basis of ethical research (Declaration of Helsinki, Fortaleza 2013). The now well-known horrible 
history of abuse and exploitation of vulnerable persons in research has served to emphasise the 
point (Beecher 1963, Pappworth 1967, Annas and Grodin 1992). However this genuine concern for 
the vulnerability of those who lack the capacity to consent has created an ethical dilemma. Involving 
adults in research in circumstances when they lack or lose the capacity to consent has been legally 
problematic and remains ethically troubling.  An absolute ban on the involvement of people who 
cannot consent may be as the only effective measure to protect the vulnerable but it would have the 
negative consequence that important, often life-saving research for the direct benefit of those 
individuals could not be conducted. The effect of a ban is that those very people who would most 
benefit from research are unable to benefit (Chalmers 2007). An equal and related concern has been 
consistently raised by researchers, namely that a too stringent insistence upon, what Roberts et al 
(2011) call the ‘rituals of consent’ may also be detrimental.  In the recent past researchers and 
Research Ethics Committees (REC) were forced to employ an ethical ‘fudge’ with regard to research 
involving adults who lacked capacity. In such cases either the research was justified on the basis of 
the ‘doctrine of necessity’ or else a ‘proxy’ consent for the incapacitated person was given by the 
next of kin or closest relative. However such practices had no basis in law and left the participant, an 
already vulnerable person, open to further exploitation because there were no legal safeguards. 
These actions also left the researcher and REC open to legal challenge since the actions violated the 
principles of common law and left them open to a charge of unethical practice.  
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There is now a legal framework which permits researchers to involve people who lack the capacity to 
consent. Such research must be reviewed and approved by a properly constituted REC, meet the 
strict criteria for justifying such research to involve adults who lack capacity (ALC) and adhere to the 
rigorous safeguards for the protection of research participants. With a specific focus on pre-hospital 
and emergency medicine research (PHER) this paper reviews the main provisions of the legislation as 
set out in the Mental Capacity Act (MCA 2005) and The Medicines for Human Use (Clinical Trials) 
Regulations (2004/1031) for involving ALC in research. The paper describes the legal framework and 
responsibilities of researchers and discusses some of the challenging ethical issues which inevitably 
arise. It is vital that researchers are familiar with the legal requirements that apply to research and 
are able to articulate sound reasoning with regard to the many ethical issues such research 
inevitably raises. This paper’s particular focus is a timely consideration of the issue of conducting 
research that is time-critical, that is; research which must be initiated within a particular time 
window for it to be effective, as this is a common factor within PHER. 
It must be noted that the MCA applies to England and Wales only, Scotland introduced legislation via 
The Adults with Incapacity (Scotland) Act 2000 and Northern Ireland is currently processing its own 
legislation. This paper will only address the context of adults in England and Wales though the 
ethical issues are common across all contexts. 
 
Background 
The Mental Capacity Act 2005 (MCA) took force in 2007; the long-awaited legislation that addressed 
the legal lacuna regarding decisions made on behalf of adults deemed unable to consent for 
themselves.  There was a long lead into the enactment of the MCA beginning in 1989 with the Lord 
Chancellor’s request for the Law Commission to review the situation of adults unable to consent for 
themselves (Bartlett and McHale 2003). There were several subsequent reports which scoped the 
wide range of issues that a comprehensive legal framework would need to engage with (Law 
Commission 1995, Lord Chancellor’s Department 1997). The question of whether to address the 
inclusion of adults lacking capacity (ALC) in health and social care research was only raised at a late 
stage of the process and, initially, research was not addressed in the draft  Mental Incapacity Bill 
(House of Lords, House of Commons 2003).  It was on the recommendation of the Joint Scrutiny 
Committee (JSC 2002-03) that the provisions for research were introduced into the legislation, 
recognising that not to do so would jeopardise the development of treatments for incapacitating 
conditions.  The final version which passed into legislation did include provisions for research 
(sections 30-34 MCA 2005). It must be noted that research was not the main focus of the MCA but 
rather the provision of a legal framework which covered all aspects of care, treatment, and the 
financial affairs of adults lacking capacity (Code of Practice 2007:15). Although the research 
provisions constitute a short section of the MCA they do empower REC to approve research 
involving ALC and provide grounds on which researchers may justify the inclusion of ALC. A key 
feature of the MCA is that it is grounded on common law principles and as such it does not permit 
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‘proxy’ consent for adults, however, it does set out the conditions under which research involving 
ALC may be conducted but without consent. The MCA, read in conjunction with the Code of Practice 
(2007) also sets out the responsibilities of researchers when conducting research involving ALC. The 
MCA addresses all instances of ‘intrusive’ research involving ALC, including research conducted in 
the social care setting, however it explicitly excludes research that is a clinical trial of a drug or 
medicine. Clinical trials are governed by separate legislation, The Medicines for Human Use (Clinical 
Trials) Regulations (2004/1031); hence forth referred to as The Regulations. Researchers working in 
PHER must be familiar with common law principles, the research provisions of the MCA and, where 
the research involves a clinical trial, The Regulations. 
The Mental Capacity Act 2005 and its implications for PHER 
Up to the point of the MCA coming into force in 2007 the Law was insufficient with regard to the 
wide range of decisions concerning adults who lack capacity for which the common law doctrine of 
necessity was inadequate (Bartlett and McHale 2003). The MCA 2005 brought in a legal framework, 
which is now well established, and offers a mechanism for those who are caring for or treating 
people who lack capacity to do so lawfully, so long as they act within the framework of the MCA and 
accompanying Code of Practice (2007). 
The MCA framework ought to be an adequate remedy for the concerns raised by critics such as 
Chalmers (2007) and Roberts et al (2011) as it permits a scientifically robust, ethically sound 
research project to be given a favourable opinion by a REC. Though critics have argued that the 
provisions do not go far enough. 
The research provisions of the MCA and how they apply to PHER 
The research provisions of the MCA 2005 are set out in sections 30 – 34 and make it lawful to carry 
out “intrusive” research involving people without the capacity to consent for themselves. “Intrusive” 
research refers to research which, under common law, consent of the participant is required 
([s.30(2)]). Intrusive research need not be physically invasive and may include clinical research, 
access to personal data, or other forms of qualitative research but excluding research that is 
classified as a clinical trial(MCA 2005 [s.30 (4-5)]). There are some circumstances in which consent is 
not mandatory, such as research that utilizes non-identifiable data, identifiable data with approval of 
the Health Research Authority (The Health Service (Control of Patient Information) Regulations 2002, 
as Amended by Section 117 of the Care Act 2014). Where researchers intend to recruit ALC then 
[s.30 (4)] requires that the research is approved by an “appropriate body”; for England this means 




In order to explore the legal requirements and the attendant ethical issues of conducting PHER it is 
useful to consider a possible (fictional) research context such as a device related study (see Fig. 1) 
St. Elsewhere NHS Foundation Trust: Emergency Management of Respiratory Problems (EMAP). St.  
Fig. 1 
 
St. Elsewhere ambulance service plans to investigate whether pre-hospital Continuous Positive 
Airway Pressure (CPAP) decreases mortality and reduces respiratory distress in adult patients with 
acute cardiogenic pulmonary oedema.  Participants will be randomized to CPAP or standard 
respiratory supportive care which will be delivered by trained paramedics following diagnosis and 
if necessary telephone discussion with a hospital-based clinician.  The trial will use a CE marked 
device.  Participants will be followed-up for up to 3 months post intervention. 
 
Prior to commencing the study the project must have a favourable opinion from an appropriate 
body; a recognized REC.  
All researchers seeking to conduct a study including ALC must design a methodology that is 
compatible with the MCA both in broad principle and with specific attention to the research 
provisions.  The MCA is based upon five broad principles which are there to guide the actions of 
professionals and carers in their approach towards ALC. The principles reflect legal standards within 
common law and other relevant statutes such as the Human Rights Act (1998). They are also 
premised upon ethical approaches to the respect for persons; requiring professionals and carers to 
work in supportive ways to enable people to make their own decisions in as wide a sphere as 
possible. The principles have direct implications for researchers in terms of how they design their 
strategies for the inclusion, recruitment and safe-guarding of research participants. Researchers 
must take reasonable steps to demonstrate to the REC the ways in which the five principles have 
informed their research protocol.  The principles will now be discussed with reference to the EMAP 
study. 
Applying the 5 principles 
The first two principles are concerned with judgments about capacity and steps to be taken to 
enable a person to make a decision for themselves. Principle 1 states: “People must be assumed to 
have capacity unless it is established that they lack capacity.” Principle 2 states: “Before treating 
people as unable to make a decision, all practicable steps to help them do so must be tried.” With 
regard to these principles, researchers working on the EMAP study must consider the range of 
circumstances in which they may encounter a potential research participant. For example they could 
be responding to an emergency call to attend a patient at home and find Mr. Smith, an elderly man, 
alone and in acute respiratory distress.  
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The principle of presumption of capacity requires the researchers to recognize that a conscious 
person capable of communicating is likely to retain some, albeit limited capacity for decision-making. 
The MCA emphasizes that capacity is decision specific so researchers must respect that most people 
with impaired capacity will nevertheless retain decision-making powers for some aspects of their 
life. The key issue in these circumstances is to apply a suitable form of assessment of Mr. Smith’s 
capacity to consent and not merely presume that he lacks capacity.  The MCA guidance on this is 
that a person is judged to be lacking capacity if, due to “an impairment or disturbance in the 
functioning of the mind or the brain” (MCA 2005 [s.2(1)]) they are unable to: “understand 
information relevant to the decision, retain the information, use or weigh the information or 
communicate his decision (by any means)” (MCA 2005 [s.2(3)]) The second principle makes it a 
requirement to support people with relevant impairments to make their own decisions by taking all 
relevant steps to do so. While it may be reasonable to consider that Mr. Smith’s “mind or brain” is 
likely to be impaired due to anoxia, anxiety or for other reasons, the researchers must nevertheless 
explain the purpose and relevant risks and benefits associated with the study. This can be done 
quickly by a verbal account of the study; though brief written details ought to be available. The 
details of this procedure can be agreed in advance with the REC. At the very least, alerting Mr. Smith 
to the potential for being entered into a study provides him with an opportunity to refuse to be in 
the study; a fundamental expression of his autonomy. The right to refuse, for whatever reason, is 
also consistent with principle 3: “People should not be treated as unable to make a decision merely 
because they make an unwise decision.” 
 As with any instance of clinical or research related procedures a verbal explanation ought to 
accompany all interventions. The MCA does not however require a lengthy delay to initiating 
research or therapeutic procedures and here principle 4: “Acts or decisions on behalf of people who 
lack capacity must be in their best interests” is relevant. This can have several implications but two 
are particularly significant. The first is that there must be grounds for believing that being entered 
into a study is not against the interests of the participant. This claim needs to be established before 
commencement of the study by showing, for example, that there is equipoise between the two or 
more, potential arms of the study. The second is that any refusal to be in the study will not result in 
detrimental prejudice. Therefore should Mr. Smith refuse to participate in the study he ought to be 
treated according to the current standard protocol.  The MCA imposes a duty on those working with 
adults with impaired decision-making capacity to make decisions that are compatible with their 
wishes, but always in their best interests (Principles [s.1(3-6)], Donnelly 2009).   
The fifth principle states: “Before any act or decision, the person responsible must consider whether 
the purpose could be achieved in a less restrictive way.” This is a steer to researchers to design a 
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protocol that is the least invasive and intrusive for example by considering the range of personal 
data collected, the number of clinical procedures/ assessments the subject is exposed to and to 
consider ways of minimizing research procedures. 
The requirements for a favourable opinion from a REC. 
Before any participant can be recruited EMAP must have a favourable opinion from a REC. The 
criteria used by the REC are set out in s.31 of the MCA as summarized in fig 2.  When applying to a 
REC the researcher will be asked to indicate their intention to include ALC. Selecting the appropriate 
response on the Integrated Research Application System form (IRAS) application form will populate 
the form with questions related to s.31. 
MCA S. 31 Criteria for including ALC 
Fig. 2 
1.   Research must be connected with an impairing condition affecting the participant (P) or its 
treatment. 
2.  Research of equal effectiveness cannot be carried out if confined to participants with capacity. 
3. (a) Research must have the potential to benefit P without imposing a disproportionate burden, 
or (b) Provide knowledge of the causes or treatment of others with same condition, and involve 
negligible risk to P, not interfere significantly with freedom of action or privacy, or be unduly 
invasive or restrictive. 
 
 
With regard to criterion 1 the researchers must demonstrate that the focus of the research is 
relevant to an impairing condition or its treatment and so must provide evidence, for example in the 
context of EMAP, that breathing problems related to cardiac failure are likely to impair brain 
function and thinking due to anoxia. The research must also meet criterion 2 and show that it is 
necessary and not merely convenient or desirable to include ALC in order to conduct the research. 
The proposed research should have the potential to be of benefit to the participant, or those with a 
similar condition, involve negligible risk and “not interfere significantly with freedom of action or 
privacy, or be unduly invasive or restrictive” [s31(6)]; a criterion which echoes principle 5. Although 
the MCA cannot provide detailed guidance on how to interpret the requirements the onus is on the 
researchers to provide for the REC a well-reasoned case supported by evidence. 
 
Safeguards for the participant who lacks capacity 
For some the decision to provide a lawful basis for the inclusion of adults unable to consent for 
themselves is crossing a moral line. However the MCA together with the Code of Conduct (2007) 
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detail a number of important safeguards. One of these is the requirement to consult others (s.32) to 
ensure that any decision to include an ALC is not against their interests. Therefore researchers must 
seek advice from a person (a “consultee” [MCA s.32(2-3)]) who knows the candidate participant and 
is concerned for their welfare (see also Department of Health and Welsh Assembly Government 
2007). The researcher must inform the consultee that their role is to advise the researcher as to 
whether recruiting the person concerned is consistent with what the participant would likely choose 
for him or her self if they had the capacity to do so (MCA [s.32(4)]). Several commentators regard 
such “substituted judgment” approaches with some scepticism and see them as highly vulnerable to 
abuse (Buchanan and Brock 1990, Torke et al 2008). There are certainly several foreseeable 
problems with substituted judgment approaches for example, can the researcher be sure that the 
consultee’s advice does reflect the wishes and values of the participant? Can the researcher judge 
whether the opinions expressed are those of the consultee or the patient? A further potential 
problem is for both the researcher and/or the consultee to confuse the process of consent with the 
process of consultation. It must be clear to both parties that when an adult, and for the MCA this 
includes those who are 16 years and older, lacks the capacity to consent no other person can 
consent for them. Though the MCA empowers researchers to recruit without consent it must be 
under conditions of strict adherence to the legal safeguards and in accordance with any conditions 
set out by the REC. However it is likely that a person willing to act as a consultee will be concerned 
for the welfare and interests of the person who is unable to consent. In addition, and independent of 
the advice offered by the consultee, the researcher must monitor the status of the participant and 
not hesitate to withdraw them from the study should they give any indication that they are 
distressed by the research procedures or express a wish to be withdrawn. The diligent use of the 
consultee procedures combined with the other safeguards the MCA requires means that important 
research for the benefit of people with impairing conditions can be conducted lawfully and ethically 
(Johansson and Broström 2014). 
A research participant who loses capacity during a research project must be immediately withdrawn 
from the study unless the project has a favourable REC opinion under the MCA. The loss of capacity 
requires the initiation of consultee procedures.  
Emergency Research 
Within the context of the fictional EMAP study what is permissible if Mr. Smith is judged to lack the 
capacity to consent for the study and there is no potential consultee available? The MCA Section 
32(9) would allow Mr. Smith to be entered into the study either with the agreement of a doctor who 
is independent of the study or in accordance with a procedure agreed with the REC in advance. The 
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advice of a consultee on whether Mr. Smith should continue in the study should be sought as soon 
as possible.  
A real and much more challenging example of emergency research procedures is illustrated by the 
Airways2 study. Airways2 is a randomized controlled trial of two airway devices, a supraglottic 
airway device versus tracheal intubation, applied in the context of out of hospital cardiac arrest. The 
nature of the research is such that any potential participant in need of airway support would be in 
no condition to consent to participate in the study. The initial research intervention, airway support 
with one or other of the devices, is both time-critical and of the utmost urgency and clearly qualifies 
as “emergency research”. Since the researchers will also be the treating clinicians at the scene, and 
will have a duty of care to treat their patient in a timely and efficient manner, there is unlikely to be 
an opportunity to consult others even if a competent consultee could be identified under such 
fraught conditions. Surviving participants will be followed up for a period of 6 months. As the 
protocol describes (Benger 2015) participants who recover capacity will be invited to consent to 
their continued involvement with the study which is consistent with MCA s. 32(9). For participants 
who do not recover capacity then consultee procedures will be initiated in accordance with the 
MCA. This study is one of the few examples of intrusive and invasive research carried out without 
consent but entirely lawfully within the provision of MCA. Since there is no provision for post hoc 
(after the event) consent. The consent of the recovered participant can only be for his or her 
ongoing involvement in the research. Prior to the enactment of the MCA there was no lawful way in 
which a randomized study of this kind could take place. 
MCA in summary:  
PHER that is not a clinical trial of a drug but is intrusive in the sense defined above will fall within the 
remit of the MCA. In the design of such a project the researcher must consider whether it is: 
necessary to include adults who lack capacity to consent, provide for those who can consent for 
themselves to do so, and have appropriate procedures in place for consulting others with regard to 
those who cannot consent. In some instances procedures for the recruitment of participants without 
consent and without the use of a consultee may be justified under emergency procedures that have 
the prior agreement of a REC. Some studies may need to employ all three methods as parallel 
recruitment strategies because the legal requirement to presume capacity or consult others must be 
respected in the relevant circumstances.  
Clinical Trials in PHER 
The Regulations give legal force to two EU Directives, EU Clinical Trials Directive and the Good 
Clinical Practice Directive (2001/20/EC). The Regulations make informed consent a condition of 
participation in a clinical trial, but in contrast to the MCA and common law approaches, they also 
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allow that a legal representative can represent a person who lacks capacity. A legal representative 
may be a relative or close friend, or a doctor who is independent of the study. The trial must also 
relate directly to the patient’s condition and there must be grounds to expect that the participant 
will benefit from the study with no or negligible risk (The Regulations: Schedule 1 Part 4.) However 
even though The Regulations allow for proxy consent by a legal representative the law is still 
regarded by some as restrictive especially with regard to research that can only be conducted in 
urgent circumstances, is time-critical and potentially life-saving (Roberts et al 2003, Stobbart et al 
2006). The Thrombolysis in Cardiac Arrest (TROICA) study Spöhr et al (2005) a randomized trial of 
thrombolysis therapy in out-of-hospital cardiac arrest, is a pioneering example of research in which 
the importance of waiving consent to allow “emergency” research was strongly demonstrated. Even 
though the results were negative for the intervention the project has become a classic example of 
the importance of such studies as did the CRASH trial (corticosteroid randomization after significant 
head injury) (2005) which demonstrated the detrimental effects of the current clinical standard of 
administration of steroids for acute head injury.  
The subsequent amendment to The Regulations (2006/2984) set out conditions in which adults who 
lacked capacity might be admitted into an emergency trial of a medicinal product without their 
consent. Though the amendment has been widely supported by the research community it has 
proven controversial and, as Pattinson (2012) points out, the EU Directive on which the amendment 
is based does not contain an explicit waiver of consent for emergency research. The European 
Commission’s draft Regulation (2012) is likely to resolve this issue once it comes into force in 2016 
but in the meantime the anomaly remains. The PARAMEDIC2 trial is a current double blind, 
randomized placebo controlled trial of the use of adrenaline in out-of-hospital cardiac arrest. The 
trial is justified on the basis that there is equipoise, because it is not possible to state  based on 
current levels of knowledge, whether the administration of adrenalin in out-of-hospital cardiac 
arrest is a benefit to patients or not. The trial has proved controversial for a number of reasons 
including the fact that participants will not be informed of their participation; a key requirement 
within the EU Directive. Critics of this approach like Stirton and Stirton (2014) have argued that a 
scientifically weaker design is ethically preferable than a placebo study without informed consent; 
though this remains a highly contested point. Despite the controversy the trial is currently running 
and has a favourable opinion from a REC in which the conditions for emergency recruitment without 
consent have been agreed. Consent to be continued in the study beyond the initial intervention 
must be obtained from the participant or their legal representative as soon as possible after their 




There is no doubt that the person who is incapacitated and unable to consent for themselves is in a 
very vulnerable position. They are potentially even more vulnerable in the medical research context. 
Researchers have a duty of care not to create or exploit such potential vulnerability, to act always in 
the patient’s best interests, using research methods that are of negligible risk or no risk at all. Not to 
do so is regarded as unethical and may also be unlawful. It can also be argued that not to conduct 
research involving those who cannot consent, when there is no other means of gaining knowledge to 
benefit such persons, is equally unethical. Conducting research in the pre-hospital and emergency 
setting is additionally challenging because the safeguards offered through consulting with, or gaining 
the consent of, those who know and are close to the patient is often difficult or impossible. The MCA 
and amendments to The Regulations allow adults who cannot consent for themselves to be entered 
into research under strict legal procedures which include a number of important safe-guards. The 
decade since the legislation has been active has been a steep learning-curve for researchers and REC 
members (Dixon-Woods and Angell 2009) and there are no doubt lessons still to be learned.  
In addition to providing an overview of the legislation relevant to PHER, this paper has also provided 
guidance for researchers who are planning or are actively engaged in PHER. When seeking a 
favourable ethical opinion to conduct research involving ALC the onus is upon the researchers not 
only to know and understand the legal requirements that apply but to implement these 
requirements through a highly ethical lens. The safety and best interests of the research participant 
who is unable to consent ought to be paramount. The involvement of adults who lack capacity in 
intrusive research or clinical trials should be recognised as ethically challenging and researchers 
should not only act lawfully but subject their own practices to critical ethical scrutiny. 
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